Global Gram-Negative Bacterial Infection Therapeutics Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17771503 | Publishing Date : 22-Mar-2021 | No. of pages : 95
Detailed TOC of Global Gram-Negative Bacterial Infection Therapeutics Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Enteral Treatment
1.2.3 Parenteral Treatment
1.2.4 Topical Treatment
1.3 Market by Application
1.3.1 Global Gram-Negative Bacterial Infection Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gram-Negative Bacterial Infection Therapeutics Market Perspective (2016-2027)
2.2 Gram-Negative Bacterial Infection Therapeutics Growth Trends by Regions
2.2.1 Gram-Negative Bacterial Infection Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gram-Negative Bacterial Infection Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Gram-Negative Bacterial Infection Therapeutics Industry Dynamic
2.3.1 Gram-Negative Bacterial Infection Therapeutics Market Trends
2.3.2 Gram-Negative Bacterial Infection Therapeutics Market Drivers
2.3.3 Gram-Negative Bacterial Infection Therapeutics Market Challenges
2.3.4 Gram-Negative Bacterial Infection Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gram-Negative Bacterial Infection Therapeutics Players by Revenue
3.1.1 Global Top Gram-Negative Bacterial Infection Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Gram-Negative Bacterial Infection Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gram-Negative Bacterial Infection Therapeutics Revenue
3.4 Global Gram-Negative Bacterial Infection Therapeutics Market Concentration Ratio
3.4.1 Global Gram-Negative Bacterial Infection Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gram-Negative Bacterial Infection Therapeutics Revenue in 2020
3.5 Gram-Negative Bacterial Infection Therapeutics Key Players Head office and Area Served
3.6 Key Players Gram-Negative Bacterial Infection Therapeutics Product Solution and Service
3.7 Date of Enter into Gram-Negative Bacterial Infection Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gram-Negative Bacterial Infection Therapeutics Breakdown Data by Type
4.1 Global Gram-Negative Bacterial Infection Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Type (2022-2027)
5 Gram-Negative Bacterial Infection Therapeutics Breakdown Data by Application
5.1 Global Gram-Negative Bacterial Infection Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027)
6.2 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type
6.2.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027)
6.3 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application
6.3.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027)
6.4 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country
6.4.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027)
7.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type
7.2.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027)
7.3 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application
7.3.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027)
7.4 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country
7.4.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type
8.2.1 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application
8.3.1 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region
8.4.1 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027)
9.2 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type
9.2.1 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application
9.3.1 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country
9.4.1 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type
10.2.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application
10.3.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country
10.4.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Baxter
11.1.1 Baxter Company Details
11.1.2 Baxter Business Overview
11.1.3 Baxter Gram-Negative Bacterial Infection Therapeutics Introduction
11.1.4 Baxter Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.1.5 Baxter Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Gram-Negative Bacterial Infection Therapeutics Introduction
11.2.4 Sanofi Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Introduction
11.3.4 GlaxoSmithKline Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Gram-Negative Bacterial Infection Therapeutics Introduction
11.4.4 Novartis Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Gram-Negative Bacterial Infection Therapeutics Introduction
11.5.4 Pfizer Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Takeda
11.6.1 Takeda Company Details
11.6.2 Takeda Business Overview
11.6.3 Takeda Gram-Negative Bacterial Infection Therapeutics Introduction
11.6.4 Takeda Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.6.5 Takeda Recent Development
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Company Details
11.7.2 Nektar Therapeutics Business Overview
11.7.3 Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Introduction
11.7.4 Nektar Therapeutics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.7.5 Nektar Therapeutics Recent Development
11.8 Sumitomo
11.8.1 Sumitomo Company Details
11.8.2 Sumitomo Business Overview
11.8.3 Sumitomo Gram-Negative Bacterial Infection Therapeutics Introduction
11.8.4 Sumitomo Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.8.5 Sumitomo Recent Development
11.9 Targeted Genetics
11.9.1 Targeted Genetics Company Details
11.9.2 Targeted Genetics Business Overview
11.9.3 Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Introduction
11.9.4 Targeted Genetics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.9.5 Targeted Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Gram-Negative Bacterial Infection Therapeutics Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Enteral Treatment
Table 3. Key Players of Parenteral Treatment
Table 4. Key Players of Topical Treatment
Table 5. Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions (2022-2027)
Table 11. Gram-Negative Bacterial Infection Therapeutics Market Trends
Table 12. Gram-Negative Bacterial Infection Therapeutics Market Drivers
Table 13. Gram-Negative Bacterial Infection Therapeutics Market Challenges
Table 14. Gram-Negative Bacterial Infection Therapeutics Market Restraints
Table 15. Global Gram-Negative Bacterial Infection Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Gram-Negative Bacterial Infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gram-Negative Bacterial Infection Therapeutics as of 2020)
Table 18. Ranking of Global Top Gram-Negative Bacterial Infection Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Gram-Negative Bacterial Infection Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gram-Negative Bacterial Infection Therapeutics Product Solution and Service
Table 22. Date of Enter into Gram-Negative Bacterial Infection Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Gram-Negative Bacterial Infection Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Baxter Company Details
Table 63. Baxter Business Overview
Table 64. Baxter Gram-Negative Bacterial Infection Therapeutics Product
Table 65. Baxter Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Baxter Recent Development
Table 67. Sanofi Company Details
Table 68. Sanofi Business Overview
Table 69. Sanofi Gram-Negative Bacterial Infection Therapeutics Product
Table 70. Sanofi Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. GlaxoSmithKline Company Details
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Product
Table 75. GlaxoSmithKline Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Gram-Negative Bacterial Infection Therapeutics Product
Table 80. Novartis Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Pfizer Company Details
Table 83. Pfizer Business Overview
Table 84. Pfizer Gram-Negative Bacterial Infection Therapeutics Product
Table 85. Pfizer Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Pfizer Recent Development
Table 87. Takeda Company Details
Table 88. Takeda Business Overview
Table 89. Takeda Gram-Negative Bacterial Infection Therapeutics Product
Table 90. Takeda Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Takeda Recent Development
Table 92. Nektar Therapeutics Company Details
Table 93. Nektar Therapeutics Business Overview
Table 94. Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Product
Table 95. Nektar Therapeutics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Nektar Therapeutics Recent Development
Table 97. Sumitomo Company Details
Table 98. Sumitomo Business Overview
Table 99. Sumitomo Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Sumitomo Recent Development
Table 101. Targeted Genetics Company Details
Table 102. Targeted Genetics Business Overview
Table 103. Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Product
Table 104. Targeted Genetics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Targeted Genetics Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Enteral Treatment Features
Figure 3. Parenteral Treatment Features
Figure 4. Topical Treatment Features
Figure 5. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Gram-Negative Bacterial Infection Therapeutics Report Years Considered
Figure 10. Global Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Players in 2020
Figure 15. Global Top Gram-Negative Bacterial Infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gram-Negative Bacterial Infection Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Gram-Negative Bacterial Infection Therapeutics Revenue in 2020
Figure 17. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Gram-Negative Bacterial Infection Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Gram-Negative Bacterial Infection Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Share by Region (2016-2027)
Figure 39. China Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Gram-Negative Bacterial Infection Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Baxter Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 63. Takeda Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 64. Nektar Therapeutics Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 65. Sumitomo Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 66. Targeted Genetics Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Keyplayers in Global Gram-Negative Bacterial Infection Therapeutics Market Size, Status and Forecast 2021-2027
BaxterSanofi
GlaxoSmithKline
Novartis
Pfizer
Takeda
Nektar Therapeutics
Sumitomo
Targeted Genetics